HER-2 Positive Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| 89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111 (NCT04757090) | Washington University School of Medicine | 2021-12-31 |
Track HER-2 Positive Cancer automatically
Every clearance here is in the API, with alerts when new ones post.